Search results
All You Need to Know About Swedish Orphan Biovitrum (BIOVF) Rating Upgrade to Strong Buy
Zacks via Yahoo News· 5 months agoSwedish Orphan Biovitrum (BIOVF) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting...
Swedish Orphan Biovitrum (BIOVF) Q3 Earnings Miss Estimates
Zacks via Yahoo News· 8 months agoSwedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of -44.44% and 7.69%,...
Nurix Therapeutics, Inc. (NRIX) Soars 8.3%: Is Further Upside Left in the Stock?
Zacks via Yahoo News· 10 months agoNurix Therapeutics, Inc. (NRIX) saw its shares surge in the last session with trading volume being...
Is Swedish Orphan Biovitrum (BIOVF) Stock Undervalued Right Now?
Zacks via Yahoo News· 10 months agoHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and...
Swedish Orphan Biovitrum (BIOVF) Earnings Expected to Grow: Should You Buy?
Zacks via Yahoo News· 12 months agoSwedish Orphan Biovitrum (BIOVF) doesn't possess the right combination of the two key ingredients...
Are Medical Stocks Lagging Alcon (ALC) This Year?
Zacks via Yahoo News· 1 year agoFor those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Alcon (ALC)...
Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?
Zacks via Yahoo News· 1 year agoInvestors interested in Medical stocks should always be looking to find the best-performing...
AstraZeneca (AZN), Sanofi Simply RSV Antibody Agreement Terms
Zacks via Yahoo News· 1 year agoAstraZeneca (AZN) and Sanofi (SNY) revise the contractual terms of the agreement for Beyfortus....
Why Is Apellis Pharmaceuticals, Inc. (APLS) Down 7% Since Last Earnings Report?
Zacks via Yahoo News· 1 year agoIt has been about a month since the last earnings report for Apellis Pharmaceuticals, Inc. (APLS)....
Pharma Stock Roundup: FDA Updates for SNY, PFE & Others, EU Nod to AZN Cancer Combo
Zacks via Yahoo News· 1 year agoThis week, the FDA approved Sanofi’s SNY Altuviiio, a new class of factor VIII therapy for...